Table 5.
Statistical analyses of Estrogen E2 (Pg/ml) and Estrogen receptor ER (ng/ml) levels in female patients group according to Sokal score
| Sokal score | |||
|---|---|---|---|
| < 0.8 low risk | 0.8 – 1.2 intermediate risk | > 1.2 High risk | |
| Estrogen (pg/ml) | (n = 7) | (n = 7) | (n = 6) |
| Range | 30.90 – 253.0 | 10.50 – 227.0 | 47.20 – 151.0 |
| Mean ± SE | 141.95 ± 111.05 | 77.32 ± 51.25 | 90.35 ± 23.62 |
| p | 0.683 | ||
| p1 | 0.355 | ||
| p2 | 1.000 | ||
| p3 | 0.564 | ||
| ER | (n = 5) | (n = 6) | (n = 9) |
| Range | 1.90 – 7.80 | 0.56 – 5.02 | 0.57 – 7.15 |
| Mean ± SE | 4.31 ± 1.45 | 2.43 ± 0.82 | 2.94 ± 0.78 |
| Hp | 0.174 | ||
| p1 | 0.088 | ||
| p2 | 0.189 | ||
| p3 | 0.346 | ||
P: P value for Kruskal Wallis test for comparing E2 between the three categories, Sig.bet.grps was done using Post Hoc Test (Dunn's multiple comparisons test).Hp: Hp value for Kruskal Wallis test for comparing ER between the three categories, Sig.bet.grps was done using Post Hoc Test (Dunn's multiple comparisons test)
p1: p value comparing between < 0.8 and 0.8 – 1.2 p2: p value comparing between < 0.8 and > 1.2
p3: p value comparing between 0.8 – 1.2 and > 1.2 *: Statistically significant at p ≤ 0.05